Sustainability | March 20, 2025
UFlex’s FlexiTubes to showcase sustainable beauty packaging at COSMOPROF Italy 2025
FlexiTubes will showcase range of eco-friendly and innovative tube options
FlexiTubes will showcase range of eco-friendly and innovative tube options
Apalutamide is an androgen receptor inhibitor indicated for the treatment of patients with metastatic castration-sensitive prostate cancer
This program aims to develop a fully human monoclonal antibody against a novel immune checkpoint protein that enables T cell activation
Experts urge early detection & better access to care
Empagliflozin and its Fixed Drug Combinations (FDCs) have been launched under the brand names Glempa, Glempa –L and Glempa-M
Will add UNLOXCYT (cosibelimab-ipdl), the first and only FDA-approved anti-PD-L1 treatment for metastatic or locally advanced cutaneous squamous cell carcinoma (cSCC) to Sun Pharma's global onco-derm franchise
Company expects to begin building four more domestic manufacturing sites this year and add 13,000 high-wage manufacturing and construction jobs in America
MET-X, a novel metallo-beta-lactamase (MBL) inhibitor, has shown best-in-class performance in preclinical studies
Zongertinib would be the first orally administered, targeted therapy for previously treated patients with HER2 (ERBB2)-mutant advanced non-small cell lung cancer (NSCLC), if approved
Dr. Prabhavathi brings over 14 years of unparalleled experience in pediatrics and a specialized focus on neurodevelopmental disorders
Subscribe To Our Newsletter & Stay Updated
